VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 72 filers reported holding VOR BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,074,658 | -57.8% | 1,074,658 | 0.0% | 0.27% | +362.1% |
Q1 2024 | $2,546,939 | +5.3% | 1,074,658 | 0.0% | 0.06% | +5.5% |
Q4 2023 | $2,417,981 | +6.1% | 1,074,658 | 0.0% | 0.06% | -93.4% |
Q3 2023 | $2,278,275 | -31.4% | 1,074,658 | 0.0% | 0.84% | -18.6% |
Q2 2023 | $3,320,693 | -42.6% | 1,074,658 | 0.0% | 1.03% | -45.2% |
Q1 2023 | $5,781,660 | +80807.6% | 1,074,658 | 0.0% | 1.88% | -9.5% |
Q4 2022 | $7,146 | -99.8% | 1,074,658 | 0.0% | 2.08% | +65.1% |
Q3 2022 | $4,277,000 | -19.9% | 1,074,658 | 0.0% | 1.26% | -7.7% |
Q2 2022 | $5,341,000 | -17.7% | 1,074,658 | 0.0% | 1.36% | +11.2% |
Q1 2022 | $6,491,000 | -48.0% | 1,074,658 | 0.0% | 1.23% | -13.7% |
Q4 2021 | $12,488,000 | -25.9% | 1,074,658 | 0.0% | 1.42% | -3.8% |
Q3 2021 | $16,851,000 | – | 1,074,658 | – | 1.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,692,429 | $124,814,000 | 31.41% |
Trustees of Columbia University in the City of New York | 183,821 | $3,428,000 | 5.06% |
RA Capital Management | 11,120,973 | $207,406,000 | 3.33% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $20,042,000 | 2.05% |
Sarissa Capital Management LP | 707,010 | $13,186,000 | 1.05% |
SECTORAL ASSET MANAGEMENT INC | 405,324 | $7,559,000 | 0.61% |
Woodline Partners LP | 1,146,494 | $21,382,000 | 0.40% |
Artal Group S.A. | 550,000 | $10,258,000 | 0.21% |
NEXPOINT ASSET MANAGEMENT, L.P. | 50,000 | $933,000 | 0.20% |
Orbimed Advisors | 833,333 | $15,542,000 | 0.16% |